首页> 外文期刊>Experimental and clinical transplantation >The Paradox of Increasing Waiting List Mortality and Declining Utilization of Deceased Donor Grafts in Kidney Transplant
【24h】

The Paradox of Increasing Waiting List Mortality and Declining Utilization of Deceased Donor Grafts in Kidney Transplant

机译:增加等待名单死亡率的悖论以及肾移植中死亡的供体移植的利用率下降

获取原文
           

摘要

Kidney transplant (KTx) is the gold standard treatment for end-stage renal disease because of clear benefits in terms of survival, cost, and quality of life over dialysis.1 However, a recent analysis of the United Network for Organ Sharing database showed that, in the era of organ shortage, transplant candidates receive a large number of viable organ offers that were declined on their behalf by transplant centers.2 Therefore, we analyzed the organ utilization and wait list mortality of KTx candidates in the Eurotransplant database during the period from 2009 to 2018. Over the last decade, there were a consistently high number of patients actively waiting for KTx. Similarly, the number of new registrations, removals, and re-registrations on wait lists remained unchanged, reflecting the persistent high demand for kidney grafts (data not shown). When we assessed the characteristics of KTx candidates on wait lists, we noted a significant increase in the number of patients who are waiting 5 years, are highly sensitized (panel reactive antibodies 85%), and are older than 65 years (Figure 1A; all P .001). More importantly, we also noted a significant increase in mortality for KTx wait list candidates from 4.8% in 2009 to 5.7% in 2018 (P .005). During the same period, the wait list mortality for heart and lung transplant candidates decreased from 20.8% to 11.1% (P = .001) and from 15.8% to 13.4% (P = .001), respectively (Figure 1B). When we evaluated the kidney donation and allocation process, we noted a mild decline in the number of organs transplanted, despite stable offer rates (P = .06). This trend seems to be explained by a significant increase in the number of organs that were discarded (P .001) (Figure 1C). This finding might reflect some deficiencies in the allocation process at the level of the transplant centers. However, this trend was not seen in other solid organs and seems to be organ specific, highlighting the need for better organ utilization in KTx.
机译:肾移植(KTX)是终末期肾病的黄金标准治疗,因为在透析的生存,成本和生活质量方面的良好益处1然而,最近对器官共享数据库的联合网络的分析表明,在器官短缺时代,移植候选人通过移植中心接收大量可行的器官提议,他们通过移植中心拒绝了它们.2,我们在该期间分析了EurotRansplant数据库中KTX候选人的器官利用率和等待列表死亡率从2009年到2018年在过去十年中,有一贯的高数量的患者积极等待KTX。类似地,等待列表的新注册,删除和重新注册的数量保持不变,反映了对肾移植的持续性高需求(数据未显示)。当我们评估在等待列表KTX候选人的特点,我们注意到在谁的病人正在等待&GT数量显著上升; 5年,高度致敏(面板反应抗体& 85%),比65岁左右(图1A;所有P& .001)。更重要的是,我们还指出,在2018年的2009年的4.8%的ktx等候名单候选人的死亡率显着增加至5.7%(P& .005)。在同一时期,心脏和肺移植候选的等待列表死亡率从20.8%降至11.1%(p = .001),分别为15.8%至13.4%(p = .001)(图1b)。当我们评估肾脏捐赠和分配过程时,尽管提供了稳定的报价率(P = .06),我们注意到移植器官数量的温和下降。这种趋势似乎通过丢弃的器官数量的显着增加来解释(P <.001)(图1c)。这一发现可能会在移植中心的水平体现在分配过程中的一些不足之处。然而,这一趋势并没有出现在其他实体器官,似乎是器官特异性,突出对KTX更好地利用器官的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号